Monoclonal antibodies: Pharmacological relevance

被引:4
|
作者
Kaur, Jasleen [1 ]
Badyal, O. K. [1 ]
Khosla, P. P. [1 ]
机构
[1] Christian Med Coll & Hosp, Dept Pharmacol, Ludhiana, Punjab, India
关键词
antibodies; biological response modifiers; cancer chemotherapy; immunosuppressant; immunotherapeutics;
D O I
10.4103/0253-7613.30755
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Monoclonal antibodies (MAbs), a new class of biological agents, are used these days in therapeutics and diagnosis. MAbs also labeled as 'magic bullets', are highly specific antibodies produced by a clone of single hybrid cells formed in the laboratory by fusion of B cell with the tumor cell. The hybridoma formed yields higher amount of MAbs. MAbs can be produced in vitro and in vivo. Animals are utilized to produce MAbs, but these antibodies are associated with immunogenic and ethical problems. Of late, recombinant DNA technology, genetic engineering,phage display and transgenic animals are used to produce humanized MAbs or pure human MAbs, which have fewer adverse effects. MAbs alone or conjugated with drugs, toxins, or radioactive atoms are used for treatment of cancer, autoimmune disorders, graft rejections, infectious diseases, asthma, and various cardiovascular disorders. New MAbs are being developed which are more specific and less toxic.
引用
收藏
页码:5 / 14
页数:10
相关论文
共 50 条
  • [31] Monoclonal antibodies
    Hantraye, Benedicte
    Clere, Nicolas
    ACTUALITES PHARMACEUTIQUES, 2015, 54 (551): : 18 - 21
  • [32] Monoclonal antibodies
    Hartung, H. -P.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S29 - S29
  • [33] Monoclonal antibodies
    不详
    FORMULARY, 2001, 36 (11) : 816 - 816
  • [34] Monoclonal antibodies
    Boyer, Michael
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S173 - S174
  • [35] MONOCLONAL-ANTIBODIES TO THE NEUROPEPTIDE CORTICOTROPIN RELEASING-FACTOR (CRF) - THEIR USE AS PHARMACOLOGICAL TOOLS
    VANOERS, JWAM
    TILDERS, FJH
    PHARMACEUTISCH WEEKBLAD-SCIENTIFIC EDITION, 1987, 9 (05) : 298 - 298
  • [36] Relevance of the first extracellular domain of the CD5 molecule in the binding by specific monoclonal antibodies
    Lozano, F
    Calvo, J
    Places, L
    Simarro, M
    Roca, A
    Vives, J
    TISSUE ANTIGENS, 1996, 48 (4-II): : TC107 - TC107
  • [37] ApoptosisClinical Relevance and Pharmacological Manipulation
    Urmila Thatte
    Sharadini Dahanukar
    Drugs, 1997, 54 : 511 - 532
  • [38] CLINICAL RELEVANCE OF PHARMACOLOGICAL INTERACTIONS
    Endel, G.
    Neumann, K.
    VALUE IN HEALTH, 2010, 13 (03) : A150 - A151
  • [40] Monoclonal antibodies in cancers - Monoclonal antibodies in the therapy of advanced colorectal cancer
    Schalhorn, A
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2005, 55 (11): : 709 - 710